期刊
BMC MEDICINE
卷 20, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12916-022-02588-7
关键词
Healthcare; Ethnicity; SARS-CoV-2; COVID-19; Vaccination; Hesitancy
资金
- MRC-UK Research and Innovation [MR/V027549/1]
- Department of Health and Social Care through the National Institute for Health Research (NIHR)
- NIHR Biomedical Research Centres
- NIHR
- NIHR Career Development Fellowship [CDF-2017-10-008]
- Academy of Medical Sciences Springboard Award [SBF005\1047]
- National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM)
- NIHR Leicester Biomedical Research Centre (BRC)
- NIHR Development and Skills Enhancement Award
- BREATHE-The Health Data Research Hub for Respiratory Health [MC_PC_19004]
- SAIL Databank
- UK Research and Innovation Industrial Strategy Challenge Fund
- National Institutes of Health Research (NIHR) [CDF-2017-10-008] Funding Source: National Institutes of Health Research (NIHR)
This study found that nearly a quarter of UK HCWs were hesitant about receiving a regular SARS-CoV-2 vaccination. Black HCWs, those with previous COVID-19 episodes, and those who have not received influenza vaccination were more likely to be hesitant. On the other hand, HCWs who received influenza vaccination and trusted official vaccine information were less likely to hesitate.
Background Regular vaccination against SARS-CoV-2 may be needed to maintain immunity in 'at-risk' populations, which include healthcare workers (HCWs). However, little is known about the proportion of HCWs who might be hesitant about receiving a hypothetical regular SARS-CoV-2 vaccination or the factors associated with this hesitancy. Methods Cross-sectional analysis of questionnaire data collected as part of UK-REACH, a nationwide, longitudinal cohort study of HCWs. The outcome measure was binary, either a participant indicated they would definitely accept regular SARS-CoV-2 vaccination if recommended or they indicated some degree of hesitancy regarding acceptance (probably accept or less likely). We used logistic regression to identify factors associated with hesitancy for receiving regular vaccination. Results A total of 5454 HCWs were included in the analysed cohort, 23.5% of whom were hesitant about regular SARS-CoV-2 vaccination. Black HCWs were more likely to be hesitant than White HCWs (aOR 2.60, 95%CI 1.80-3.72) as were those who reported a previous episode of COVID-19 (1.33, 1.13-1.57 [vs those who tested negative]). Those who received influenza vaccination in the previous two seasons were over five times less likely to report hesitancy for regular SARS-CoV-2 vaccination than those not vaccinated against influenza in either season (0.18, 0.14-0.21). HCWs who trusted official sources of vaccine information (such as NHS or government adverts or websites) were less likely to report hesitancy for a regular vaccination programme. Those who had been exposed to information advocating against vaccination from friends and family were more likely to be hesitant. Conclusions In this study, nearly a quarter of UK HCWs were hesitant about receiving a regular SARS-CoV-2 vaccination. We have identified key factors associated with hesitancy for regular SARS-CoV-2 vaccination, which can be used to identify groups of HCWs at the highest risk of vaccine hesitancy and tailor interventions accordingly. Family and friends of HCWs may influence decisions about regular vaccination. This implies that working with HCWs and their social networks to allay concerns about SARS-CoV-2 vaccination could improve uptake in a regular vaccination programme.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据